ESR1 and psoriasis: Similarly, NOX4 (Zheng et al. 2019), CDK5 (Staniszewska et al. 2023), FLT3 (Zhu et al. 2021), ER‐α (Iwano et al. 2020), and CDK1 (Li et al. 2021) are targets for psoriasis treatment.